DRIO - DarioHealth Corp.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.43
-0.06 (-4.03%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close1.49
Open1.46
Bid1.36 x 3000
Ask2.20 x 5000
Day's Range1.43 - 1.50
52 Week Range1.32 - 4.70
Volume38,800
Avg. Volume94,943
Market Cap19.788M
Beta-0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.94
Earnings DateMar 20, 2018 - Mar 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.25
Trade prices are not sourced from all markets
  • DarioHealth Launches Sales of Dario™ Blood Glucose Monitoring System on Amazon Prime
    PR Newswire4 days ago

    DarioHealth Launches Sales of Dario™ Blood Glucose Monitoring System on Amazon Prime

    NEW YORK and CAESAREA, Israel, Feb. 20, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch and first sales of its Dario™ Blood Glucose Monitoring System on Amazon. Distribution on Amazon strengthens DarioHealth's online retail presence, as it provides its users and potential clients with additional purchasing and shipping options, including shipping via Amazon Prime, as all fulfillment is being managed by Amazon. With over 300 million users, Amazon is one of the largest online retailers.

  • DarioHealth Partners With a Leading Diabetes Clinic
    PR Newswire12 days ago

    DarioHealth Partners With a Leading Diabetes Clinic

    NEW YORK and CAESAREA, Israel, Feb. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has partnered with the Diabetes and Endocrinology Consultants of Pennsylvania, LLC, the clinical practice of Dr. Alan Schorr and Dr. Arvind Cavale, with expertise in incorporating state of the art technology in the treatment of people with Type 1 and Type 2 diabetes. With this market expansion, the Dario™ Blood Glucose Monitoring System will be offered in their clinic, which provides a wide-range of treatment therapies for over 5,000 patients. The product was chosen because it is compact, accurate, and it has the ability for users and healthcare practitioners to simplify diabetes management via a smartphone.

  • DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study
    PR Newswire16 days ago

    DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study

    NEW YORK and CAESAREA, Israel, Feb. 8, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has entered into an agreement with a pharmaceutical company conducting a clinical study for a new drug related to managing diabetes. The pharmaceutical company is seeking FDA clearance for this drug and has selected DarioHealth to run and track the blood glucose readings of participants in the clinical study.

  • GlobeNewswire24 days ago

    dynaCERT Appoints Colonel Yalon Farhi as Director, Provides Corporate Update Including Equity Financing and Note Redemption

    TORONTO, Jan. 31, 2018-- dynaCERT Inc. is pleased to announce the appointment of Colonel Yalon Farhi to its Board of Directors. Colonel Farhi is a colonel in the Israeli Defense Forces, serving since 1998. ...

  • DarioHealth Introduces iPhone 7, iPhone 8, and iPhone X Compatible Smart Glucose Meter to the Australian Market
    PR Newswirelast month

    DarioHealth Introduces iPhone 7, iPhone 8, and iPhone X Compatible Smart Glucose Meter to the Australian Market

    CAESAREA, Israel, Jan. 17, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has launched the Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System in the Australian market. The Lightning®-enabled device ensures that Apple consumers "Down Under" will be able to connect the Dario smart glucose meter to the latest iOS handsets, including the brand-new iPhone X.

  • DarioHealth Begins Selling iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter in the U.K.
    PR Newswire2 months ago

    DarioHealth Begins Selling iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter in the U.K.

    CAESAREA, Israel, Jan. 8, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has successfully sold the first Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System in the United Kingdom, according to schedule. The Lightning®-enabled device ensures that consumers will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8 and iPhone X. Apple iOS has just over 50% market share in the U.K. With additional potential users, DarioHealth believes that it will be able to quickly increase U.K.-driven revenues and achieve greater market penetration. This news comes shortly after the company's recent announcement of receiving the Therapeutic Goods Administration (TGA) Mark in the Australian market for the same Lightning®-enabled device.  Sales of the device are expected to begin in Australia mid-January. DarioHealth expects to hear from the U.S. Food and Drug Administration (F.D.A.) about necessary clearance over the next few months.

  • What You Must Know About DarioHealth Corp’s (NASDAQ:DRIO) Major Investors
    Simply Wall St.2 months ago

    What You Must Know About DarioHealth Corp’s (NASDAQ:DRIO) Major Investors

    I am going to take a deep dive into DarioHealth Corp’s (NASDAQ:DRIO) most recent ownership structure, not a frequent subject of discussion among individual investors. The impact of a company’sRead More...

  • DarioHealth Granted Another U.S. Patent Strengthening its Core Technology
    PR Newswire2 months ago

    DarioHealth Granted Another U.S. Patent Strengthening its Core Technology

    Dror Bacher, COO and Vice President of R&D at DarioHealth, commented, "We are very excited to finish off 2017 with this news. This patent has already been part and parcel of the Dario Blood Glucose Monitoring System since it entered the U.S. market and showcases our commitment to further enhancing our core technologies on our native mobile solutions. "With this patent, DarioHealth strengthens its IP rights and enables us to be compatible with more devices.

  • PR Newswire2 months ago

    DarioHealth Gains Regulatory Approval in Australia for iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter

    CAESAREA, Israel, Dec. 18, 2017 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it received the Therapeutic Goods Administration (TGA) Mark for its Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System in Australia. The regulatory approval ensures that consumers in the Australian market will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8 and iPhone X.

  • Does Zero-Debt Make DarioHealth Corp (DRIO) A Financially Strong Company?
    Simply Wall St.3 months ago

    Does Zero-Debt Make DarioHealth Corp (DRIO) A Financially Strong Company?

    DarioHealth Corp (NASDAQ:DRIO), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is DRIO willRead More...

  • Should You Be Content With DarioHealth Corp’s (DRIO) 55.7% Earnings Growth?
    Simply Wall St.3 months ago

    Should You Be Content With DarioHealth Corp’s (DRIO) 55.7% Earnings Growth?

    Today I will take a look at DarioHealth Corp’s (NASDAQ:DRIO) most recent earnings update (30 September 2017) and compare these latest figures against its performance over the past few years,Read More...

  • DarioHealth Corp. :DRIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
    Capital Cube3 months ago

    DarioHealth Corp. :DRIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis DarioHealth Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of DarioHealth Corp. – Ionis Pharmaceuticals, Inc., Exact Sciences Corporation and Mateon Therapeutics, Inc. (IONS-US, EXAS-US and MATN-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)

  • DarioHealth Launches Version 3.5 of its MyDario App to Support iPhone 7 and iPhone 8
    PR Newswire3 months ago

    DarioHealth Launches Version 3.5 of its MyDario App to Support iPhone 7 and iPhone 8

    CAESAREA, Israel, Nov. 20, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced the availability of update version 3.5 of its MyDario app. The app update includes support for DarioHealth's new Lightning compatible device for iPhone 7 and iPhone 8 which was recently awarded the CE Mark. The DarioHealth lightning adapter is currently under consideration for regulatory approval with the United States Food and Drug Administration and the Therapeutic Goods Administration (TGA) in Australia.

  • What Can We Expect for DarioHealth Corp (DRIO) Moving Forward?
    Simply Wall St.3 months ago

    What Can We Expect for DarioHealth Corp (DRIO) Moving Forward?

    DarioHealth Corp (NASDAQ:DRIO), a USD$16.18M small-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as anRead More...

  • DarioHealth Reports Third Quarter 2017 Results
    PR Newswire3 months ago

    DarioHealth Reports Third Quarter 2017 Results

    Record Quarterly Revenues of $1.4 Million Continued Reduction in Cash Burn Android and New Initiatives to Accelerate Growth CAESAREA, Israel , Nov. 14, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), ...

  • ACCESSWIRE3 months ago

    DarioHealth Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 14, 2017 / DarioHealth Corp. (NASDAQ: DRIO ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 14, 2017 at 9:00 AM Eastern ...

  • ACCESSWIRE3 months ago

    Investor Network Invites You to the DarioHealth Third Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, November 14, 2017

    CAESAREA, ISRAEL / ACCESSWIRE / November 13, 2017 / DarioHealth Corp. (NASDAQ: DRIO) will host a conference call and live webcast to discuss the results of third quarter 2017, to be held Tuesday, November ...

  • DarioHealth to Host Third Quarter Conference Call on November 14, 2017
    PR Newswire4 months ago

    DarioHealth to Host Third Quarter Conference Call on November 14, 2017

    Earnings and Business Update Conference Call Scheduled for 9:00am ET CAESAREA, Israel , Nov 6, 2017 , /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO ), a leading global digital health company with mobile ...

  • PR Newswire4 months ago

    DarioHealth Expanding its Mobile Health and Data Offerings to Include a Business-to-Business Solution

    DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it is increasing its B2B2C offering by facilitating organizations to digitize targeted healthcare solutions in patients with diabetes. The strategic move comes on the eve of Diabetes Awareness Month, and DarioHealth has officially launched its new corporate website http://www.dariohealth.com to showcase its first-class capabilities. The new platform, called Dario Engage, helps healthcare providers in all aspects of user engagement, including enrollment, coaching and ongoing communications with the end-users.

  • SmarterAnalyst4 months ago

    DarioHealth Corp (DRIO) Scores CE Mark; Shares Soar 36%

    DarioHealth Corp (NASDAQ:DRIO) investors are overwhelmingly excited after the smartphone-connected glucometer company announced that it is now allowed to place the "CE" Mark on the Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System for distribution in the European Union (EU) and its member states. The news ensures that consumers, beginning in the UK market, will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8. The launch of Apple's smartphones with only a Lightning connector posed a unique challenge to the entire mobile ecosystem.

  • PR Newswire4 months ago

    DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter

    CAESAREA, Israel, Oct. 18, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it received the CE Mark for its Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System. The news ensures that consumers, beginning in the UK market, will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8. The launch of Apple's smartphones with only a Lightning connector posed a unique challenge to the entire mobile ecosystem.

  • Should You Sell DarioHealth Corp (DRIO) For This Reason?
    Simply Wall St.5 months ago

    Should You Sell DarioHealth Corp (DRIO) For This Reason?

    As the USD $18.61M market cap DarioHealth Corp (NASDAQ:DRIO) released another year of negative earnings, investors may be on edge waiting for breakeven. Since DRIO is currently burning more cashRead More...

  • DarioHealth Launches into the German Diabetes Market
    PR Newswire5 months ago

    DarioHealth Launches into the German Diabetes Market

    CAESAREA, Israel, Oct. 3, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced it expands its global reach with a successful launch into the German market, making its smart diabetes platform available for the first time in the EU's largest market, both by population and GDP. With this launch, DarioHealth is now commercially available in 9 countries around the world. DarioHealth will operate its direct-to-consumer channel, leveraging its in-depth knowledge from other markets to provide new opportunities for more than 8 million Germans living with diabetes.

  • PR Newswire5 months ago

    DarioHealth's MyDario to Appear on The Dr. Oz Show

    CAESAREA, Israel and NEW YORK, Sept. 27, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced that its MyDario product is expected to appear on The Dr. Oz Show on today. The segment features Tracy Herbert who is passionate about helping people live a healthier life. Tracy has lived with Type 1 diabetes for almost 40 years, which has shaped her thirst for knowledge in health, fitness, and wellness.

  • DarioHealth's CEO and MyDario to Appear on The Dr. Oz Show
    PR Newswire5 months ago

    DarioHealth's CEO and MyDario to Appear on The Dr. Oz Show

    CAESAREA, Israel and NEW YORK, Sept. 26, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced that its CEO, Erez Raphael, and the MyDario product is expected to appear on The Dr. Oz Show on Wednesday, September 27, 2017. The segment features Tracy Herbert who is passionate about helping people live a healthier life.